biostudies-literatureTakita SNEI NIH HHSNational Eye InstituteResearch to Prevent BlindnessSchool of Medicine, Indiana UniversityNational Institutes of HealthNIH HHSe23606https://www.ebi.ac.uk/biostudies/studies/S-EPMC11047207biostudies-literatureUnknown38(8)Rhodopsin mislocalization encompasses various blind conditions. Rhodopsin mislocalization is the primary factor leading to rod photoreceptor dysfunction and degeneration in autosomal dominant retinitis pigmentosa (adRP) caused by class I mutations. In this study, we report a new knock-in mouse model that harbors a class I Q344X mutation in the endogenous rhodopsin gene, which causes rod photoreceptor degeneration in an autosomal dominant pattern. In Rho^Q344X/+ mice, mRNA transcripts from the wild-type (Rho) and Rho^Q344X mutant rhodopsin alleles are expressed at equal levels. However, the amount of RHO^Q344X mutant protein is 2.7 times lower than that of wild-type rhodopsin, a finding consistent with the rapid degradation of the mutant protein. Immunofluorescence microscopy indicates that RHO^Q344X is mislocalized to the inner segment and outer nuclear layers of rod photoreceptors in both Rho^Q344X/+ and Rho^Q344X/Q344X mice, confirming the essential role of the C-terminal VxPx motif in promoting OS delivery of rhodopsin. The mislocalization of RHO^Q344X is associated with the concurrent mislocalization of wild-type rhodopsin in Rho^Q344X/+ mice. To understand the global changes in proteostasis, we conducted quantitative proteomics analysis and found attenuated expression of rod-specific OS membrane proteins accompanying reduced expression of ciliopathy causative gene products, including constituents of BBSome and axonemal dynein subunit. Those studies unveil a novel negative feedback regulation involving ciliopathy-associated proteins. In this process, a defect in the trafficking signal leads to a reduced quantity of the trafficking apparatus, culminating in a widespread reduction in the transport of ciliary proteins.FASEB journal : official publication of the Federation of American Societies for Experimental BiologyRhodopsin mislocalization drives ciliary dysregulation in a novel autosomal dominant retinitis pigmentosa knock-in mouse model.PMC11047207R01EY029680R01 EY028884R01EY028884R01 EY029680S10 OD023436Mann RJImanishi YLePage DConlon RATakita SS Imanishi SMiyagi MHarikrishnan HJahan SfalseRhodopsin mislocalization drives ciliary dysregulation in a novel autosomal dominant retinitis pigmentosa knock-in mouse model.Rhodopsin mislocalization encompasses various blind conditions. Rhodopsin mislocalization is the primary factor leading to rod photoreceptor dysfunction and degeneration in autosomal dominant retinitis pigmentosa (adRP) caused by class I mutations. In this study, we report a new knock-in mouse model that harbors a class I Q344X mutation in the endogenous rhodopsin gene, which causes rod photoreceptor degeneration in an autosomal dominant pattern. In Rho^Q344X/+ mice, mRNA transcripts from the wild-type (Rho) and Rho^Q344X mutant rhodopsin alleles are expressed at equal levels. However, the amount of RHO^Q344X mutant protein is 2.7 times lower than that of wild-type rhodopsin, a finding consistent with the rapid degradation of the mutant protein. Immunofluorescence microscopy indicates that RHO^Q344X is mislocalized to the inner segment and outer nuclear layers of rod photoreceptors in both Rho^Q344X/+ and Rho^Q344X/Q344X mice, confirming the essential role of the C-terminal VxPx motif in promoting OS delivery of rhodopsin. The mislocalization of RHO^Q344X is associated with the concurrent mislocalization of wild-type rhodopsin in Rho^Q344X/+ mice. To understand the global changes in proteostasis, we conducted quantitative proteomics analysis and found attenuated expression of rod-specific OS membrane proteins accompanying reduced expression of ciliopathy causative gene products, including constituents of BBSome and axonemal dynein subunit. Those studies unveil a novel negative feedback regulation involving ciliopathy-associated proteins. In this process, a defect in the trafficking signal leads to a reduced quantity of the trafficking apparatus, culminating in a widespread reduction in the transport of ciliary proteins.2024-01-01T00:00:00Z2024 Apr2026-06-01T10:17:13.199Z2025-07-10T03:09:09.294ZS-EPMC110472073864846510.1096/fj.202302260RR10.1096/fj.202302260rr